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Synopsis
The species-specific, as well as organ-specific expression of regulated necrosis (RN)-related molecules, is not known.
We determined the expression levels of tumour necrosis factor receptor-1 (TNFR1), receptor activated protein kinase
(RIPK)1, RIPK3, mixed lineage kinase domain-like (MLKL), CASP8, Fas-associated protein with death domain (FADD),
cellular inhibitor of apoptosis protein (CIAP)1, CIAP2, glutathione peroxidase-4 (GPX4), cyclophilin D (CYPD), CASP1,
NLRP3 and poly(ADP-ribose) polymerase-1 (PARP1) in human and mouse solid organs. We observed significant
differences in expression of these molecules between human and mice. In addition, we characterized their expression
profiles in acute as well as persistent tissue injury and chronic tissue remodelling using acute and chronic kidney
injury models. We observed that the degree and pattern of induction of RN-related molecules were highly dependent
on the trigger and disease pathogenesis. Furthermore, we studied their expression patterns in mice with lupus-like
systemic autoimmunity, which revealed that the expression of MLKL, GPX4 and PARP1 significantly increased in the
spleen along disease progression and CASP1, RIPK1, RIPK3 and CYPD were higher at the earlier stages but were
significantly decreased in the later stages. In contrast, in the kidney, the expression of genes involved in pyroptosis,
e.g. NLRP3 and CASP1 were significantly increased and TNFR1, RIPK1, RIPK3, CIAP1/2 and GPX4 were significantly
decreased along the progression of lupus nephritis (LN). Thus, the organ- and species-specific expression of RN-related
molecules should be considered during designing experiments, interpreting the results as well as extrapolating the
conclusions from one species or organ to another species or organ respectively.
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INTRODUCTION
For almost two decades apoptosis was considered to be the only
programmed form of cell death and necrosis was felt to be an
‘accidental’ cell death passively induced by physiochemical in-
sults [1]. However, recent evidence revealed multiple pathways
of regulated necrosis (RN) that share common morphological
features e.g. cellular leakage, cytoplasmic granulation and or-
ganelle and/or cellular swelling [2]. Based on the engagement of
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distinct signalling pathways, RN is currently categorized as
necroptosis, ferroptosis, mitochondria permeability transition
(MPT)-RN, pyroptosis, parthanatos, catastrophic mitosis, pod-
optosis and neutrophil extracellular trap (NET)-associated cell
death, NETosis etc. [2,3].
Necroptosis
Necroptosis is triggered by death receptors and requires
the receptor activated protein kinase (RIPK)3-dependent
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phosphorylation of mixed lineage kinase domain-like (MLKL)
inducing plasma membrane pore formation [4,5]. Tumour nec-
rosis factor receptor-1 (TNFR1)-mediated necroptosis is con-
sidered a prototype form of RN. TNFR1 stimulation recruits
RIPK1, which possesses important kinase-dependent and scaf-
folding functions that either inhibit or trigger necroptosis and
apoptosis [6]. Upon deubiquitination, RIPK1 is translocated to
the cytosol where it targets RIPK3 via the RHIM domain [2].
TNFR1 activation may also lead to apoptosis; however, the de-
ficiency of caspase-8 [7], a Fas-associated protein with death
domain (FADD) [8], FLICE-like inhibitory protein [9] and cel-
lular inhibitor of apoptosis proteins (CIAPs) 1 and 2 [10] in-
duce necroptosis. In addition to the death receptors, interferons,
toll-like receptors (TLRs), intracellular RNA or DNA sensors as
well as inorganic crystals trigger necroptosis [11,12]. Further-
more, distinct stimuli involve the necroptosis pathway into NET
formation-related neutrophil death, known as ‘suicidal NETosis’
[13,14].
Ferroptosis
Iron-dependent accumulations of intracellular lipid reactive oxy-
gen species (ROS) lead to cellular necrosis, which is termed
as ferroptosis [15]. Ferroptosis is triggered by chemical inhibi-
tion of the cellular cystine/glutamate antiporter system Xc, using
erastin, leading to depletion of intracellular generation of GSH,
an antioxidant. Glutathione peroxidase-4 (GPX4) reduces hydro-
gen peroxide to water using GSH and therefore, suppression of
GPX4 results in ferroptosis [16].
MPT-RN
Under stressful cellular conditions, MPT is accompanied by the
unspecific opening of the MPT pore on the inner membrane
of mitochondria leading to necrosis, termed as MPT-RN [2].
Cyclophilin D (CYPD) is an important regulator of the pore
opening since both genetic deficiency and chemical inhibition of
CYPD have been shown to protect cells from MPT-RN [17–19].
Pyroptosis
Pyroptosis is a proinflammatory form of RN. The activation of
NLRP3 or other inflammasomes leads to caspase-1 activation
that cleaves the pro-IL1β and proIL-18 into their active subunits
to allow their cellular release by cell membrane rupture, termed
as pyroptosis [2,20,21].
Parthanatos
Poly(ADP-ribose) polymerase-1 (PARP1) overactivation causes
PARylation of proteins that deplete cells of NAD+ and induce
RN, termed as parthanatos [2,22].
RN and inflammation can induce each other in an auto-
amplification loop of necroinflammation resulting in exaggerated
cell death and inflammation that may lead to organ failure [23–
25]. Since, most experiments are conducted in mice the relev-
ance for the human disease remains a concern, and discrepancies
in organ-specific expression levels between species were previ-
ously shown for pattern recognition receptors (PRRs), C-type
lectins and TLR accessory molecules [26–31]. We hypothesized
the same for the RN-related molecules, and hence, determined
their mRNA expression profiles in human and mice organs as well
as in murine autoimmunity, acute tissue injury and progressive
tissue fibrosis.
MATERIALS AND METHODS
Human solid organ total RNA and cDNA preparation
All human solid organ total RNA from pools of healthy human
tissues were purchased from Clontech. An equal amount of total
RNA from each individual sample was used as a template in
cDNA preparation with Superscript II (Invitrogen). As only a
single pool was available for each organ, no studies on biological
replicates allowing statistics could be performed. According to
Clontech, all human organ samples were purchased and imported
in accordance with all local laws and regulations.
Mouse solid organ cDNA preparation for qRT-PCR
experiments
Ten to twelve-week old adult C57BL/6 male mice were obtained
from Charles River. Mice were housed in groups of five under
specific pathogen-free conditions with unlimited access to food
and water. Mice were killed by cervical dislocation. RNA was
isolated from freshly harvested tissues as described [30]. All or-
gans were kept in RNA later solution and RNA was isolated with
an equal amount of tissue mass. RNA was purified with Pure
Link RNA Mini Kit (Ambion) according to manufacturer’s in-
structions. All RNA samples were digested with DNAse enzyme
and additional washing steps were performed to remove traces
of DNAse. RNA concentrations were measured with NanoDrop
1000 Spectrophotometer. Only samples with absorbance 260/280
between 1.95 and 2.05 were considered as pure RNA, the integ-
rity of the total RNA was determined by electrophoresis on 2%
(w/v) agarose gels as described.
Animal studies
Groups of 7–8-week old C57BL/6 male mice (n=5–10) under-
went bilateral or unilateral renal pedicle clamping for 35 min
followed by reperfusion as a model of ischaemia-reperfusion as
described [32,33]. Body temperature was maintained at 37 ◦C
throughout the procedure using a heating plate (Kleintier-OP-
Tisch M12511, Medax) and an egg breeding device (Octagon
20 Advance, Brinsea Products). Mice underwent bilateral ped-
icle clamping were killed after 24 h of reperfusion to study
acute ischaemic injury whereas mice underwent unilateral ped-
icle clamping were killed at day 5, 10 and 35 to study CKD after
AKI. Injured and contralateral kidneys were harvested for RNA
isolation and histology analysis. Contralateral kidneys served as
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internal control kidneys. To induce acute oxalate nephropathy,
mice received a single intraperitoneal injection of 100 mg kg− 1
of sodium oxalate (Santa Cruz Biotechnology) and 3% sodium
oxalate in drinking water and kidneys were harvested after 24 h
for RNA isolation and histology analysis [11,34]. For cisplatin
nephropathy model, mice received a single intraperitoneal in-
jection of 20 mg kg− 1 of cisplatin (Sigma–Aldrich) and kidneys
were harvested after 3 days for RNA isolation and histology ana-
lysis [35]. Chronic oxalate nephropathy was induced by feeding
mice an oxalate-rich diet that was prepared by adding 50 μmol/g
sodium oxalate to a calcium-free standard diet (Ssniff) as recently
described [36]. Mice were killed at day 7, 14 and 21 [36]. For the
lupus model, groups of female MRL/WT or MRL/lpr mice with
spontaneous lupus-like autoimmunity were killed at 6, 10 and
14 weeks as described [37,38]. MRL/lpr female mice develop a
lupus-like disease at week 10, which is further aggravated in the
next weeks. Thus, week 14, a time point when the mice already
show fully developed the lupus-like disease, was chosen. Week
6 was used as a baseline control [38]. Kidneys and spleens were
harvested for RNA isolation and RT-PCR. All experimental pro-
cedures were performed according to the German animal care and
ethics legislation and had been approved by the local government
authorities.
Quantitative real time-PCR
An equal amount of RNA (1 μg) was used to prepare cDNA [31].
Complementary DNA was performed with Superscript II reverse
transcriptase (Thermo Fisher), 5× first-strand buffer (Thermo
Fisher), DTT (Invitrogen), dNTPs (GE Healthcare), linear ac-
rylamide (Ambion), hexanucleotide (Roche) and RNasin (Pro-
mega). Reverse transcriptase reaction was performed for 90 min
at 42 ◦C then the reaction was heated at 85 ◦C for 5 min using a
Mastercycler pro (Eppendorf). RN-related molecule mRNA ex-
pression in human and mouse solid organs, as well as diseases
model, were quantified by RT-PCR using GAPDH as house-
keeper gene for human samples and 18s rRNA for mouse samples
as described previously [30]. Each PCR reaction (20 μl) involved
10× Taq Polymerase Buffer, Taq Polymerase, dNTPs, BSA, PCR
Optimizer, SYBR Green dye, MgCl2, gene specific primers and
0.2 μl of synthesized cDNA. SYBR Green dye fast two-step
detection protocol from Light Cycler 480 (Roche) running pro-
gramme was used for amplification. Each amplification step in-
cluded initiation step 95 ◦C, annealing step 60 ◦C and amplifica-
tion step 72 ◦C and was repeated 40 times. Gene-specific primers
(300 nM, Metabion) were used as listed in Table 1. Double-
distilled H2O was used as negative control for target and house-
keeper genes. Specific primer for each target was designed us-
ing the primer designing tool (NCBI) and in silico specificity
screen (BLAST) was performed. The lengths of amplicons were
between 90 and 120 bp. The kinetics of the PCR amplification
(primer efficiency) was calculated for each set of primers. The
efficiency-corrected quantification was performed automatically
by the Light Cycler 480 based on extern standard curves describ-
ing the PCR efficiencies of the target and the reference gene [ratio
= EtargetCPtarget (control − sample)/ErefCPref (control − sample)]. The high
confidence algorithm was used to reduce the risk of the false posit-
ive crossing point. All the samples that rise above the background
fluorescence (crossing point Cp or quantification cycle Cq)
between 5 and 40 cycles during the amplification reaction were
considered as detectable. The melting curves were analysed for
every sample to detect unspecific products and primer dimers. To
visualize the similarity and differences in gene expression profiles
among the samples, hierarchical cluster analysis was performed
using algorithms incorporated in the open-source software Mul-
tiExperiment Viewer (MeV) version 4.9 [39]. Differentially ex-
pressed mRNAs were screened by Volcano Plot between log 2
(fold change) gene expression [unstandardized signal] against
− log 10 (P-value) from the t test [noise-adjusted/standardized
signal] [40].
Histopathology
The harvested kidney tissues were fixed in 4% neutral-buffered
formalin followed by dehydration in graded alcohols and embed-
ded in paraffin. For periodic acid–Schiff (PAS) and haematoxylin
and eosin (H&E) staining or immunostaining, 4 μm sections
were deparaffinized, rehydrated, transferred into citrate buffer
and either autoclaved or microwave treated for antigen retrieval
and processed as described [12]. Tubular injury was scored by
assessing the percentage of necrotic tubules and presence of tubu-
lar casts. For immunostaining, following primary antibodies were
used: RIPK3, MLKL and SMA (Abcam), Collagen1α1 (Dako).
Statistics
Data were expressed as mean +− S.E.M. Comparisons between
groups were performed using unpaired Student’s two-sided t test.
A P-value less than 0.05 indicated statistical significance.
RESULTS
Regulated necrosis-related molecule mRNA
expression in adult human tissues
We quantified the mRNA expression levels of RN-related mo-
lecules involved in necroptosis, e.g. TNFR1, RIPK1, RIPK3,
MLKL, CASP8, FADD and CIAP1 and CIAP2; ferroptosis, e.g.
GPX4; MPT-RN, e.g. CYPD; pyroptosis, e.g. CASP1, NLRP3;
parthanatos, e.g. PARP1 using qRT-PCR in healthy human or-
gans. All of these molecules were constitutively expressed in the
human spleen; however, the mRNA expression levels of MLKL,
NLRP3 and FADD were generally low (Figure 1A). GPX4 and
CYPD expressions were higher in testis, whereas expression of
CIAP1 and CIAP2 was higher in the thymus but all remained low
in any other solid organs tested. Lung expressed higher levels
of RIPK1, MLKL and CYPD. The later was also expressed at
higher levels in the liver. Further, higher expression of CIAP1
was observed in testis. Apart from this, the mRNA expression
of most of the other molecules was markedly lower in the solid
organs compared with spleen. Thus, mRNA expression levels
of most RN-related molecules are low in healthy solid organs
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Table 1 Primers used for RT-PCR
Heading Forward sequence (5′→3′) Reverse sequence (3′→5′) Accession number Efficiency
Human
TNFR1 CCGCTTCAGAAAACCACCTCAG ATGCCGGTACTGGTTCTTCCTG NM_001065 2.00
RIPK1 TATCCCAGTGCCTGAGACCAAC GTAGGCTCCAATCTGAATGCCAG NM_003804 2.24
RIPK3 GCTACGATGTGGCGGTCAAGAT TTGGTCCCAGTTCACCTTCTCG NM_006871 2.34
MLKL TCACACTTGGCAAGCGCATGGT GTAGCCTTGAGTTACCAGGAAGT NM_152649 1.98
CASP8 AGAAGAGGGTCATCCTGGGAGA TCAGGACTTCCTTCAAGGCTGC NM_033355 2.06
FADD GCTTCTGAACTCAAGCTGCG CCCGCAGGAGCTCATTTAGT NM_003824 1.97
CIAP1 CAGACACATGCAGCTCGAATGAG CACCTCAAGCCACCATCACAAC NM_001166 1.88
CIAP2 GCTTTTGCTGTGATGGTGGACTC CTTGACGGATGAACTCCTGTCC NM_001165 2.05
GPX4 ACAAGAACGGCTGCGTGGTGAA GCCACACACTTGTGGAGCTAGA NM_002085 1.88
CYPD CAGAATGGGACAGGTGGAGAAAG CTGAGAACCGTTTGTGTTGCGG NM_005038 2.07
CASP1 GCTGAGGTTGACATCACAGGCA TGCTGTCAGAGGTCTTGTGCTC NM_001257118 1.88
NLRP3 GGACTGAAGCACCTGTTGTGCA TCCTGAGTCTCCCAAGGCATTC NM_001079821 2.09
PARP1 CCAAGCCAGTTCAGGACCTCAT GGATCTGCCTTTTGCTCAGCTTC NM_001618 2.10
Mouse
TNFR1 GTGCGTCCCTTGCAGCCACT GCAACAGCACCGCAGTAGCTGA NM_011609.4 2.20
RIPK1 GACTGTGTACCCTTACCTCCGA CACTGCGATCATTCTCGTCCTG NM_009068 1.94
RIPK3 GAAGACACGGCACTCCTTGGTA CTTGAGGCAGTAGTTCTTGGTGG NM_019955 2.22
MLKL CTGAGGGAACTGCTGGATAGAG CGAGGAAACTGGAGCTGCTGAT NM_001310613 2.25
CASP8 ATGGCTACGGTGAAGAACTGC TAGTTCACGCCAGTCAGG NM_009812 2.20
FADD CACACAATGTCAAATGCCACCTG TGCGCCGACACGATCTACTGC NM_01017 2.02
CIAP1/2 GGACATTAGGAGTCTTCCCACAG GAACACGATGGATACCTCTCGG NM_007464 2.20
GPX4 CCTCTGCTGCAAGAGCCTCCC CTTATCCAGGCAGACCATGTGC NM_001037741 2.17
CYPD GGACGCTTGAAAATGTAGAGGTG GGATGACTGTCACCAGAGCCAT NM_026352 2.27
CASP1 TCAGCTCCATCAGCTGAAAC TGGAAATGTGCCATCTTCTTT NM_009807 2.01
NLRP3 TCACAACTCGCCCAAGGAGGAA AAGAGACCACGGCAGAAGCTAG NM_145827 2.04
PARP1 CTCTCCCAGAACAAGGACGAAG CCGCTTTCACTTCCTCCATCTTC NM_007415 2.15
compared with spleen except for CYPD in testis and CIAP1/2 in
the lung.
Regulated necrosis-related molecule mRNA
expression in adult murine tissues
Next, we examined the same organs from healthy, 10–12 weeks
old, C57BL/6 mice to quantify the mRNA expression levels of
the RN-related molecules as listed earlier. All molecules were
constitutively expressed in mouse spleen; however, the mRNA
expression levels of RIPK3, MLKL, FADD, GPX4 and NLRP3
were low (Figure 1B). Unlike human solid organs, RN-related
molecule mRNA expression varied between murine solid or-
gans compared with the spleen. NLRP3, RIPK3, CASP1, CASP8
and CIAP1/2 mRNA expression levels were very low in all the
solid organs tested as compared with spleen except for RIPK3 in
thymus, CASP1 and CASP8 in the colon and CIAP1/2 in thymus,
heart and testis. MLKL mRNA was expressed at higher levels in
the brain, small intestine, colon, testis and muscle. TNFR1 mRNA
levels were higher in thymus, lung, heart, colon and muscles,
whereas GPX4 mRNA levels were higher in the brain, thymus,
heart, kidney, testis and muscle. Brain, thymus, lung, heart, testis
and muscles expressed higher mRNA levels of CYPD. Thymus,
heart and muscles expressed high levels FADD mRNA. RIPK1
mRNA was only moderately expressed in thymus, heart, kid-
ney, colon and testis. PARP1 was highly expressed only in the
testis and was expressed at moderately high levels in thymus and
heart. Figure 2 compares the organ-specific RN-related molecule
mRNA expression in humans (white bars) and mice (black bars).
The graphs illustrate the obvious differences in relative mRNA
expression between humans and mice. For example, TNFR1,
MLKL and CYPD mRNA expressions were much higher in
murine organs. Human lung, liver and testis express higher
relative levels of CYPD mRNA compared with other human
solid organs. All organs except colon and liver expressed high
levels of GPX4 mRNA. Interestingly, testis express remarkably
high (up to 97-fold) levels of GPX4 mRNA compared with the
spleen. Thus, the relative mRNA expression levels of RN-related
molecules largely differ between healthy human and mouse
organs.
Regulated necrosis-related molecule expression in
acute tissue injury in mice
We further studied the changes in the expression of RN-related
molecules in transient tissue injury. Since human and mice
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Figure 1 RN-related molecules mRNA expression in adult human and mouse tissue
(A) Quantitative real-time PCR analysis was performed on cDNAs prepared from pools of healthy human tissue as described
in the ‘Materials and Methods’ section and mRNA expression levels of all the organs were normalized to GAPDH mRNA
expression level and spleen mRNA levels were illustrated in the form histograms. Whereas the mRNA expression levels of
other organs were normalized to spleen mRNA expression levels and were represented in the heatmap. (B) cDNAs derived
from five adult 12-week old C57BL/6 mice as described in ‘Materials and Methods’ section and mRNA expression levels
of all the organs were normalized to 18s rRNA expression level and the spleen mRNA levels were illustrated in the form of
histograms. Whereas the mRNA expression levels of respected other organs were normalized to spleen expression levels
and were represented in the heatmap. Data represent means +− S.E.M.
kidneys expressed relatively low mRNA levels of these molecules
as in respective spleen, we selected three independent and well-
characterized mouse models of acute kidney injury (AKI) viz.
ischaemia-reperfusion injury (IRI), acute oxalate nephropathy
and cisplatin nephropathy [11,32,34,35]. Tubular cell necrosis
and inflammation are the hallmarks of kidney injury in these
models (Supplementary Figure S1). We observed a consistent
robust induction in the mRNA levels of necroptosis-related mo-
lecules viz. RIPK3, MLKL and CIAP1/2 in all three mouse mod-
els of AKI compared with the baseline (Figures 3A and 3B). In
addition, CASP1, NLRP3 mRNA levels were significantly in-
creased only in IRI and TNFR1, CASP8 mRNA levels were sig-
nificantly increased only in acute oxalate nephropathy, whereas
RIPK1, CASP8, FADD, CYPD and PARP1 mRNA levels were
significantly decreased in cisplatin nephropathy (Figures 3A and
3B). GPX4 mRNA was not regulated in any of the three models
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Figure 2 The relative expression of RN-related molecules mRNA in different organs compared with the spleen
The respective relative human (white bars) and murine (black bars) and RN-related molecular mRNA levels from Figure 1
are illustrated. The x-axis shows mRNA expression levels of the organs normalized to spleen mRNA expression levels of
the respective species. The y-axis marks the fold-change in each direction. Note that the scale of the y-axis is different
for each organ. Data represent means +− S.E.M.
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Regulated necrosis related molecules expression
(Figures 3A and 3B). Immunohistostaining of the kidneys for
RIPK3 and MLKL confirmed the results at protein levels (Fig-
ure 3C). Together, acute tissue injuries involve consistent in-
duction of molecules involved only in the necroptosis pathway,
whereas the involvement of other RN pathways is highly depend-
ent on the trigger.
Regulated necrosis-related molecule expression in
progressive tissue injury and fibrosis in mice
Persistent and progressive tissue injury leads to the chronic tis-
sue remodelling [41,42]. During this process, several inflam-
matory cells are recruited at the site of injury to maintain the
inflammatory condition and promote tissue fibrosis by secret-
ing pro-fibrotic mediators [43,44]. To study the induction of
RN-related molecules in chronic tissue remodelling, we used
two well-characterized murine models of chronic kidney disease
(CKD) viz. progressive CKD model of chronic oxalate nephro-
pathy [36] and CKD long after AKI model [45]. The mRNA
levels of necroptosis- and pyroptosis-related molecules (TNFR1,
RIPK3, MLKL, CIAP1/2, NLRP3 and CASP1) were signific-
antly induced during the progression of chronic oxalate nephro-
pathy, except for MLKL, which was decreased in the later phase
(Figures 4A and 4B). RIPK1, CASP8, FADD, GPX4, CYPD
and PARP1 mRNA expressions were significantly decreased in
the later phase of chronic oxalate nephropathy (Figures 4Aand
4B). In contrast with the progressive CKD model, we observed
a very robust induction of all the RN-related molecule mRNA
expression in the early phase of the CKD after AKI. The mRNA
levels of RIPK3, NLRP3 and CIAP1/2 were as high as 11–12-
fold compared with the baseline. The expression levels of all
of these molecules declined with the progression of CKD after
AKI (Figures 5A and 5B). The mRNA levels of necroptosis-
and pyroptosis-related molecules (RIPK3, CIAP1/2, NLRP3 and
CASP1) remained high, however statistically insignificant, even
after 5 weeks (Figures 5A and 5B). Immunohistostaining of the
kidneys for RIPK3 and MLKL confirmed the results at the protein
level in progressive tissue fibrosis evident from smooth muscle
actin (SMA) and collagen-1α1 (Figures 4C and 5C and Supple-
mentary Figures S2 and S3). Together, the degrees of induction as
well as the duration of the decline of the levels of RN-related mo-
lecules highly depend on the pathogenesis of the chronic tissue
remodelling.
Regulated necrosis-related molecule expression in
systemic autoimmunity of MRL/lpr mice
Systemic autoimmunity is characterized by high levels of circu-
lating autoantibodies, tissue inflammation and progressive tissue
remodelling of multiple organ systems [46–48]. To study the
induction of RN-related molecules in systemic autoimmunity,
we used the model of Fas-deficient MRL/lpr mice that displays
spontaneous and similar to human systemic lupus erythematosus
(SLE)-like systemic autoimmunity [37,46,49]. We observed that
all of these molecules were constitutively expressed in the spleen
of MRL-wild-type mice (Figure 6A). Furthermore, MLKL and
GPX4 were expressed significantly high in the spleen during the
disease progression. PARP1 mRNA was expressed significantly
less at week 6, but its expression was increased significantly at
week 10 and 14 (Figures 6A and 6B). FADD mRNA followed the
similar trend of PARP1 and RIPK3 mRNA expression was signi-
ficantly more at week 6 that was almost at the baseline at week 10
and 14 in the spleen (Figures 6A and 6B). Immunostaining of the
spleen for RIPK3 and MLKL confirmed the results at the protein
levels (Figure 6C). Thus, mostly the expression of RN-related
molecules is down-regulated except for MLKL, CYPD, PARP1
and FADD in the spleen during the progression of SLE.
Regulated necrosis-related molecule expression in
progressive lupus nephritis of MRL/lpr mice
The most frequent complication of SLE is an immune complex
glomerulonephritis called lupus nephritis (LN). The pathogen-
esis of progressive renal remodelling in LN involves a variety
of extra- and intra-renal pathomechanisms [50]. Therefore, we
also assessed the expression of RN-related molecules in the kid-
neys during the progression of LN. We observed that all of these
molecules were constitutively expressed in the kidney of MRL-
wild-type mice (Figure 7A). Further, all RN-related molecule
mRNA levels were down-regulated with the progression of renal
remodelling in LN except for the molecules involved in pyrop-
tosis e.g. CASP1 and NLRP3, which were significantly high at
week 14 and FADD that was moderately increased (Figures 7A
and 7B). Unlike spleen, the mRNA expression of MLKL and
PARP1 remained unchanged and GPX4 was significantly down-
regulated at all-time points (Figures 7A and 7B). The expressions
of TNFR1, RIPK1 and CASP8 were significantly up-regulated
at week 6 and were down-regulated significantly at week 10
and 14 along with RIPK3 and CIAP1/2 (Figures 7A and7B).
We also checked the protein expression of some of these genes
in the kidneys. Immunostaining of the kidney for RIPK3 and
MLKL confirmed the results at the protein levels (Figure 7C).
Thus, similar to spleen the expression of RN-related molecules
is down-regulated except for CASP1 and NLRP3 in the kidney
during the progression of tissue remodelling in LN.
DISCUSSION
Historically, necrosis was viewed as an uncontrolled form of cell
death however, more recent studies showed that necrosis can be a
highly regulated process [2,3]. Based, on the pathways involved,
RN was classified into different categories [2,3]. Tissue injury
and inflammation are tightly associated processes, for example,
necrosis is associated with the release of intracellular danger
associated molecules (DAMPs), which induce inflammatory cy-
tokine release from the immune cells by activating TLRs [51].
Further, certain cytokines also possess the capacity to induce
RN [12]. This auto-amplification loop between RN and inflam-
mation is also referred as necroinflammation [23,24]. Our data
demonstrate that the relative mRNA expression profiles of the
RN-related molecules differ a lot between humans and mice as it
has been already described for the PRRs [28–31].
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Figure 3 RN-related molecules mRNA expression in AKI
Animal models of AKI were induced as described in ‘Materials and Methods’ section. (A) Quantitative RT-PCR was performed
on cDNAs derived from the injured kidneys. The mRNA expression levels were normalized to 18s rRNA expression level.
The histogram represents the mRNA expression levels of different genes of the wild-type kidney (control). Data represent
means +− S.E.M. The heatmap represents the relative expression of mRNA levels in different models compared with
control. (B) The statistical analysis of the mRNA expression levels of different genes in the injured kidneys compared
with control kidneys is represented using volcano graphs. P < 0.05 is considered statistically significant. Dotted lines
represent P = 0.05. (C) Representative images of renal sections stained with PAS or for RIPK3 and MLKL; Original
magnification: ×100.
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Figure 4 RN-related molecules mRNA expression in kidney remodelling in murine chronic oxalate nephropathy
Chronic oxalate nephropathy was induced in mice as described in ‘Materials and Methods’ section. (A) Quantitative
RT-PCR was performed on cDNAs derived from the kidneys of mice on day 7, 14 and 21. The mRNA expression levels were
normalized to 18s rRNA expression level. The histogram represents the mRNA expression levels of different genes of the
wild-type kidney (day 0). Data represent means +− S.E.M. The heatmap represents the relative expression of mRNA levels
at day 7, 14 and 21 compared with day 0. (B) The statistical analysis of the mRNA expression levels of different genes
in the kidneys at day 7, 14 and 21 compared with day 0 is represented using volcano graphs. P < 0.05 is considered
statistically significant. Dotted lines represent P = 0.05. (C) Representative images of renal sections stained with PAS or
for SMA and MLKL; Original magnification: ×100.
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Figure 5 RN-related molecules mRNA expression in kidney remodelling in murine CKD after IRI
CKD after unilateral renal pedicle clamping was induced in mice as described in ‘Materials and Methods’ section. (A)
Quantitative RT-PCR was performed on cDNAs derived from the kidneys of mice on day 5, 10 and 35. The mRNA expression
levels were normalized to 18s rRNA expression level. The histogram represents the mRNA expression levels of different
genes of the contralateral kidney at day 5 (control). Data represent means +− S.E.M. The heatmap represents the relative
expression of mRNA levels at day 5, 10 and 35 compared with control. (B) The statistical analysis of the mRNA expression
levels of different genes in the kidneys at day 5, 10 and 35 compared with control is represented using volcano graphs.
P < 0.05 is considered statistically significant. Dotted lines represent P = 0.05. (C) Representative images of renal sections
stained with PAS or for SMA and MLKL; Original magnification: ×100.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10 c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
Regulated necrosis related molecules expression
Figure 6 RN-related molecules mRNA expression in spleens of MRL/lpr mice
MRL/lpr mice were used as a model of systemic autoimmunity. (A) Quantitative RT-PCR was performed on cDNAs derived
from the spleens of mice on week 6, 10 and 14. The mRNA expression levels were normalized to 18s rRNA expression
level. The histogram represents the mRNA expression levels of different genes of the MRL wild-type spleen (control).
Data represent means +− S.E.M. The heatmap represents the relative expression of mRNA levels at week 6, 10 and 14
compared with control. (B) The statistical analysis of the mRNA expression levels of different genes in the spleens at week
6, 10 and 14 compared with control is represented using volcano graphs. P < 0.05 is considered statistically significant.
Dotted lines represent P = 0.05. (C) Representative images of spleen sections stained with PAS or for RIPK3 and MLKL;
Original magnification: ×200.
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Figure 7 RN-related molecules mRNA expression in kidneys of MRL/lpr mice
(A) Quantitative RT-PCR was performed on cDNAs derived from the kidneys of mice on week 6, 10 and 14. The mRNA
expression levels were normalized to 18s rRNA expression level. The histogram represents the mRNA expression levels
of different genes of the MRL wild-type kidneys (control). Data represent means +− S.E.M. The heatmap represents the
relative expression of mRNA levels at week 6, 10 and 14 compared with control. (B) The statistical analysis of the mRNA
expression levels of different genes in the kidneys at week 6, 10 and 14 compared with control is represented using
volcano graphs. P < 0.05 is considered statistically significant. Dotted lines represent P = 0.05. (C) Representative images
of renal sections stained with PAS or for RIPK3 and MLKL; Original magnification: ×400.
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Necroinflammation is the central pathomechanism of
ischaemic and toxic AKI [11,24,25,32,34,35,52]. The induction
of RIPK3, MLKL and CIAP1/2 in murine models of renal IRI,
acute oxalate nephropathy and cisplatin nephropathy suggest the
involvement of necroptosis as the main mechanism of acute tu-
bular necrosis (ATN) despite different triggers of injury – for
example, hypoxia, calcium oxalate crystals and a toxic chem-
ical respectively. Although the disease pathology is similar in
these models, the expression of other RN-related molecules, e.g.
TNFR1, RIPK1, CASP8, FADD, CYPD, CASP1, NLRP3 and
PARP1 etc. are different. This suggests that different pathomech-
anisms may lead to alike disease pathology. Interestingly, al-
though CYPD was not induced in cisplatin nephropathy as well as
CASP1, NLRP3 were not induced in acute oxalate nephropathy,
CypD-, Nlrp3- and Casp1-deficient mice show less ATN than
wild-type mice [19,34]. Furthermore, although GPX4 mRNA
levels were not much regulated, GPX4 protein depletion-related
ferroptosis has been confirmed as a mode of tubular cell death in
IRI and acute oxalate nephropathy [53,54]. Therefore, it is obvi-
ous that mRNA profiles do not always predict the functional con-
tribution of these molecules in disease processes. Nevertheless,
we observed a robust induction of RIPK3 and MLKL, two core
proteins of the necroptosis pathway, which was already shown to
contribute to ATN in all three models of AKI [11,19,35], hence
the functional contribution of other induced genes should be
tested.
Unlike acute tissue injuries, the contribution of necroinflam-
mation in the chronic tissue injury is not so clear. The presence of
leucocytes rather represents tissue repair or fibrosis [55,56]. The
chronic disease processes are characterized by low grade of per-
sistent inflammation and a more chronic wound healing kind of
tissue response involving tissue atrophy and scaring. We studied
progressive tissue fibrosis using a murine model of chronic oxal-
ate nephropathy, as well as CKD after IRI model. Although the
kinetics of up-regulation, as well as subsequent down-regulation,
was specific to disease pathology, both models showed induction
of RN-related molecules in the early phase of the disease. This
means that the maximum protective effect of cell death inhibitors
might only be achieved if applied in the early phase of progress-
ive tissue fibrosis. In addition, our data suggest that inhibitors of
necroptosis, ferroptosis or pyroptosis may also be beneficial in
delaying the progression of fibrosis, if applied in the later phase,
especially after acute injury. Furthermore, it will be interesting
to study the impact of these molecules on the macrophage phen-
otype switch during progressive fibrosis.
SLE is characterized persistent exposure to autoantigens as a
result of alterations in cell death pathways e.g. apoptosis, NETosis
etc., and clearance deficiency of dead cells [47,48]. The loss of
self-tolerance and production of autoantibodies by autoreactive
lymphocytes is the hallmark of SLE [47,48]. This is why we
mostly did not observe any regulation of RN-related molecules in
kidneys of MRL/lpr mice, except for CASP1 and NLRP3. How-
ever, the induction of these molecules is rather protective as they
have been demonstrated to suppress SLE and LN [57]. Our use of
Fas-deficient MRL/lpr mice as a model of SLE may explain the
up-regulation of FADD mRNA in the spleen. We also observed
an up-regulation in the mRNA expression of MLKL, GPX4 and
PARP1 in the spleen. Interestingly, the peripheral blood mono-
nuclear cells of patients with SLE as well as systemic sclerosis
are known to express low levels and activity of PARP1 [58–60].
However, the specific contribution of these molecules in SLE has
not yet been studied in detail.
The present study did not focus on the gender-specific dif-
ferences within the same species. However, several studies have
addressed the possible role of gender as a biological variable –
for example, lung and kidney injury, gut microbiota composition,
haematopoiesis etc. [61–65]. Therefore, the gender-specific dif-
ferences, along with organ- and species-specific differences, also
deserve a careful consideration.
Together, we have identified significant differences in the
mRNA expression profiles of the RN-related molecules in hu-
mans and murine solid organs, as well as their regulation in
murine autoimmunity, acute tissue injury and progressive tis-
sue fibrosis. Therefore, it is important to take into account these
species-specific differences to avoid misinterpretation and wrong
conclusions. These findings warrant the need to validate the func-
tional roles of these molecules, as identified in rodent studies, in
human studies as well.
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